亚博全站APP登录-平台

亚搏体育app官网入口> 亚搏手机版官方登录>公司新闻

Big news | Hemony Pharmaceutical Co., Ltd. successfully acquires Serrapeptase Enteric-coated Tablets of SCCPC

作者:海默尼药业有限公司时间:2021-08-12

22366033.png横版(有药业).png22366033.png

Recently, Hemony Pharmaceutical Co., Ltd. and SCCPC signed the Agreement on Transfer of Rights and Interests in Marketing License of Serrapeptase Enteric-coated Tablets, acquiring assets and interests including but not limited to marketing license, trademark, production technology, etc., indicating that it has completely completed the acquisition of Serrapeptase Enteric-coated Tablets, and has become the marketing license holder of this product.  After the acquisition, both parties will conduct further in-depth cooperation on commissioned production and process upgrade of product, and seek wider cooperation opportunities in other aspects. 

1628643573839070285.jpg1628643580698048986.jpg

协议签署

苏州中化成立于1993年4月,是台湾中国化学制药股份有限公司投资创建的现代化制药企业。目前主要生产药品类别包括:抗生素类、心血管类、消化类、抗过敏类、消炎镇痛类、口服降糖类等。

亚博全站APP登录成立于2006年7月,是一家从事药品研发、生产、销售及推广服务的综合性医药企业。截至目前,海默尼药业已成功完成10余项药品资产并购交易,在药品收购领域积累了丰富的经验,居于全国领先水平。


Baidu
sogou